With respect to immune inhibition and, as mentioned above, TAMs present an M2-like phenotype and thus, they are able to develop an immune suppression response through the secretion of immune suppressive molecules like TGF-β, arginase-1 or nitric oxide (NO), leading to a T-cell response blockade against tumor antigens [108,109]. Here, TGFB1 is linked to neoplasm.